Holonimia / meronimia

AAFP American Academy of Family Physicians ACC American College of Cardiology

ACCF American College of Cardiology Foundation ACE angiotensin converting enzyme

ACEP American College of Emergency Physicians ACP American College of Physicians

ACS acute coronary syndrome ACT activated clotting time

ACUITY Acute Catheterization and Urgent Intervention Triage strategy AHA American Heart Association

AMI acute myocardial infarction aPTT activated partial thromboplastin time ARTS Arterial Revascularization Therapy Study

ASA aspirin

AST, SGOT aspartate aminotransferase AV atrioventricular

BARI Bypass Angioplasty Revascularization Investigation BNP B-type natriuretic peptide

CABG coronary artery bypass graft

CABRI Coronary Angioplasty versus Bypass Revascularization Investigation CAD coronary artery disease

CAPTURE c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina trial CASS Coronary Artery Surgery Study

CCB calcium channel blocker

CCTA coronary computed tomographic angiogram CHD coronary heart disease

CI confidence interval CKD chronic kidney disease CK-MB creatine kinase-myocardial band CMR cardiac magnetic resonance

COMMIT CIOpidogrel and Metoprolol in Myocardial Infarction Trial

COX cyclooxygenase

CPR cardiopulmonary resuscitation

CREDO Clopidogrel for the Reduction of Events During Observation trial CRP C-reactive protein

CT computed tomography cTn cardiac troponin

CURE Clopidogrel in Unstable Angina to Prevent Recurrent Events trial CVD cardiovascular disease

d day

DAVIT Danish Study Group on Verapamil in Myocardial Infarction DES drug-eluting stent

DIGAMI Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction ECG electrocardiogram

ED emergency department EMS emergency medical services

EPIC Evaluation of c7E3 for the Prevention of Ischemic Complications

EPILOG Evaluation of PTCA and Improve Long-term Outcome by c7E3 GP IIb/IIIa receptor blockade

Appendix 3. Continued

EPISTENT Evaluation of Platelet IIb/IIIa Inhibitor for STENTing

ERACI-II Estudio Randomizado Argentino de Angioplastia vs. Clrugia-II ESC European Society of Cardiology

ESSENCE Efficacy and Safety of Subcutaneous Enoxaparin in Unstable Angina and Non-Q Wave Myocaridal Infarction trial FRIC FRagmin In ustable Coronary artery disease

FRISC Fast Revascularization During Instability in Coronary Artery Disease FRISC-II Fast Revascularization During Instability in Coronary Artery Disease-II GISSI Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto-1 1 trial GISSI-3 Gruppo Italiano per lo Studio della Sopravvivenza nell’infarto Miocardico

GP glycoprotein

GRACE Global Registry of Acute Coronary Events

GUSTO Global Utilization of Streptokinase and t-PA for Occluded Arteries GUSTO-II Global Use of Strategies to Open Occluded Coronary Arteries II

h hour

Hb hemoglobin

HDL-C high-density lipoprotein cholesterol

HF heart failure

HOPE Heart Outcomes Prevention Evaluation Study

HR hazard ratio

IABP intra-aortic balloon pump

ICTUS Invasive versus Conservative Treatment in Unstable coronary Syndromes ICU intensive care unit

IPT interpersonal psychotherapy INR international normalized ratio

ISAR-REACT Intracoronary stenting and Antithrombotic Regimen- Rapid Early Action for Coronary Treatment ISIS-2 Second International Study of Infarct Survival

ISIS-4 Fourth International Study of Infarct Survival IU international unit

IV intravenous

JNC 7 Seventh Joint National Committee on High Blood Pressure

kg kilogram

LAD left anterior descending coronary artery LDL-C low-density lipoprotein choloesterol LMWH low-molecular-weight heparin LV left ventricular

LVEF left ventricular ejection fraction MASS II Multicenter Anti Atherosclerotic Study II

MATE Medicine versus Angiography in Thrombolytic Exclusion MDPIT Multicenter Diltiazem Postinfarction Trial

MDRD Modification of Diet and Renal Disease METS metabolic equivalents

MI myocardial infarction MVo2 myocardial oxygen demand

NCEP National Cholesterol Education Program NHLBI National Heart, Lung, and Blood Institute

NS nonsignificant

NSTEMI non–ST-segment elevation myocardial infarction

NTG nitroglycerin

Appendix 3. Continued

NT-proBNP N-terminal B-type natriuretic peptide

OASIS Organization to Assess Strategies for Ischemic Syndromes

OR odds ratio

PCI percutaneous coronary intervention PDA personal digital assistant

PRISM Platelet Receptor Inhibition in Ischemic Syndrome Management

PRISM-PLUS Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms PTCA percutaneous transluminal coronary angioplasty

PURSUIT Platelet Glycoprotein IIb/IIIa in Unstable 16 Angina: Receptor Suppression Using Integrilin Therapy REACT Rapid Early Action for Coronary Treatment

REPLACE-2 Randomized Evaluation of PCI Linking Angiomax to reduced Clinical Events RITA Research Group in Instability in Coronary Artery Disease trial

RR risk ratio

Sao₂ arterial oxygen saturation

SC subcutaneous

SCAI Society for Cardiovascular Angiography and Interventions

SHOCK SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK study

SoS Stent or Surgery

STEMI ST-elevation myocardial infarction STS Society of Thoracic Surgeons SVG saphenous vein graft

SYNERGY Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors trial

TACTICS-TIMI 18 Treat Angina with Aggrastat and determine Cost of therapy with Invasive or Conservative Strategy (TACTICS) TIMI-18 trial TARGET Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial

TIMI Thrombolysis In Myocardial Infarction

TnI troponin I

TnT troponin T

U units

UA unstable angina

UA/NSTEMI unstable angina/non–ST-elevation myocardial infarction UFH unfractionated heparin

VANQWISH Veterans Affairs Non–Q-Wave Infarction Strategies in Hospital

VINO Value of first day angiography/angioplasty In evolving Non-ST-Segment elevation myocardial infarction: Open randomized trial WISE Women’s Ischemia Syndrome Evaluation